RIGL vs. APP
Compare and contrast key facts about Rigel Pharmaceuticals, Inc. (RIGL) and AppLovin Corporation (APP).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: RIGL or APP.
Correlation
The correlation between RIGL and APP is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
RIGL vs. APP - Performance Comparison
Loading data...
Key characteristics
RIGL:
1.28
APP:
3.82
RIGL:
2.29
APP:
3.55
RIGL:
1.28
APP:
1.51
RIGL:
1.04
APP:
5.98
RIGL:
4.72
APP:
15.16
RIGL:
21.87%
APP:
22.48%
RIGL:
84.70%
APP:
92.83%
RIGL:
-99.37%
APP:
-91.90%
RIGL:
-98.16%
APP:
-27.35%
Fundamentals
RIGL:
$354.50M
APP:
$122.61B
RIGL:
$2.09
APP:
$5.54
RIGL:
9.49
APP:
65.40
RIGL:
-0.10
APP:
2.35
RIGL:
1.75
APP:
23.88
RIGL:
19.09
APP:
213.08
RIGL:
$203.08M
APP:
$5.14B
RIGL:
$182.05M
APP:
$3.97B
RIGL:
$47.90M
APP:
$2.63B
Returns By Period
In the year-to-date period, RIGL achieves a 17.12% return, which is significantly higher than APP's 14.45% return.
RIGL
17.12%
16.91%
-13.37%
107.28%
-0.67%
-0.10%
-5.75%
APP
14.45%
55.58%
24.37%
349.30%
109.98%
N/A
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
RIGL vs. APP — Risk-Adjusted Performance Rank
RIGL
APP
RIGL vs. APP - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Rigel Pharmaceuticals, Inc. (RIGL) and AppLovin Corporation (APP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
RIGL vs. APP - Dividend Comparison
Neither RIGL nor APP has paid dividends to shareholders.
Drawdowns
RIGL vs. APP - Drawdown Comparison
The maximum RIGL drawdown since its inception was -99.37%, which is greater than APP's maximum drawdown of -91.90%. Use the drawdown chart below to compare losses from any high point for RIGL and APP. For additional features, visit the drawdowns tool.
Loading data...
Volatility
RIGL vs. APP - Volatility Comparison
The current volatility for Rigel Pharmaceuticals, Inc. (RIGL) is 13.17%, while AppLovin Corporation (APP) has a volatility of 20.97%. This indicates that RIGL experiences smaller price fluctuations and is considered to be less risky than APP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
RIGL vs. APP - Financials Comparison
This section allows you to compare key financial metrics between Rigel Pharmaceuticals, Inc. and AppLovin Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
RIGL vs. APP - Profitability Comparison
RIGL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Rigel Pharmaceuticals, Inc. reported a gross profit of 48.92M and revenue of 53.33M. Therefore, the gross margin over that period was 91.7%.
APP - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AppLovin Corporation reported a gross profit of 1.21B and revenue of 1.48B. Therefore, the gross margin over that period was 81.7%.
RIGL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Rigel Pharmaceuticals, Inc. reported an operating income of 12.77M and revenue of 53.33M, resulting in an operating margin of 24.0%.
APP - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AppLovin Corporation reported an operating income of 663.47M and revenue of 1.48B, resulting in an operating margin of 44.7%.
RIGL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Rigel Pharmaceuticals, Inc. reported a net income of 11.45M and revenue of 53.33M, resulting in a net margin of 21.5%.
APP - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AppLovin Corporation reported a net income of 576.42M and revenue of 1.48B, resulting in a net margin of 38.8%.